Search for: "JANSSEN PHARMACEUTICALS, INC. " Results 41 - 60 of 226
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Aug 2016, 2:10 pm by Tom Lamb
Current Product Liability Litigation Cases Which Involve Popular Drugs With Serious Side Effects That Are Starting To Gain More Attention   (Posted by Tom Lamb at DrugInjuryWatch.com)   This article will feature three types of drug injury cases that are starting to gain some momentum in terms of the number of lawsuits filed against the responsible pharmaceutical companies in courts across the country. (1) Diabetes Medicines in the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors… [read post]
12 Sep 2012, 6:08 pm
California -- Johnson & Johnson unit Janssen Pharmaceuticals Inc. was vindicated Tuesday in its efforts to prevent Lupin Pharmaceuticals Inc. from making and marketing a generic version of J&J's popular birth control drug Ortho Tri-Cyclen Lo, as a New Jersey federal judge ruled that the underlying patent is valid. [read post]
15 Mar 2017, 9:47 am by Goldberg & Goldberg
  It is manufactured by Janssen Pharmaceuticals, Inc. which is a division of Johnson & Johnson under license from Mitsubishi Tanabe Pharma Corporation. [read post]
8 Jan 2010, 11:40 am by Mark Zamora
The drugs are made by Janssen, a division of Ortho-McNeil-Janssen Pharmaceuticals Inc., which is part of Johnson & Johnson. [read post]
15 Mar 2017, 9:47 am by Goldberg & Goldberg
  It is manufactured by Janssen Pharmaceuticals, Inc. which is a division of Johnson & Johnson under license from Mitsubishi Tanabe Pharma Corporation. [read post]
22 Jan 2012, 5:42 pm by admin
On January 19, 2012 Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson, announced that it had agreed to pay $158 million to settle a Medicaid fraud lawsuit in Texas which alleged that the company improperly marketed its antipsychotic drug Risperdal causing the state to overpay for the drug. [read post]
13 May 2010, 4:57 pm by mcarzima@imediainc.com
Two subsidiaries of Johnson & Johnson, Ortho-McNeil Pharmaceutical LLC and Ortho-McNeil-Janssen Pharmaceuticals Inc., have agreed to pay more than $81 million to settle allegations that they violated the False Claims Act by illegally promoting the epilepsy drug, Topomax. [read post]
9 May 2012, 5:01 am by Ray Mullman
  Circuit Judge Tim Fox determined that Johnson & Johnson and subsidiary Janssen Pharmaceuticals Inc. committed nearly 240,000 violations of the state's Medicaid fraud law — or one for each Risperdal prescription issued to state Medicaid patients over a 31/2-year period. [read post]
29 Sep 2015, 4:45 am by briadm
The plaintiff, Sonja Lemoins, filed the 90-count complaint in Madison County, Illinois, against Janssen Pharmaceuticals, Inc., Bayer Corporation and several related companies. [read post]
4 Feb 2009, 4:09 pm
  Product liability cases against large conglomerates like Ortho-McNeil-Janssen Pharmaceuticals, Inc., can often be more than most attorneys can handle. [read post]
2 Sep 2020, 1:45 pm by Tom Lamb
The Defendants named in a typical lawsuit filed on behalf of an Elmiron user who developed vision problems might be some combination of the following: JANSSEN PHARMACEUTICALS, INC., f/k/a Ortho-McNeil-Janssen Pharmaceuticals, Inc., f/k/a Janssen Pharmaceutica Inc. [read post]
11 Sep 2008, 4:55 am
Forest Laboratories, Inc. and Merck & Co. v. [read post]
13 Nov 2018, 4:17 pm by Jon L. Gelman
Grewal announced today that the State has submitted for filing a five-count lawsuit against Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson, for deceiving consumers about the dangers of two of the company’s opioid products with high potential for abuse – Nucynta and Nucynta ER. [read post]
8 Aug 2011, 12:53 pm by info@thomasjhenrylaw.com
Violations of this act have led to multi-million dollar settlements with other pharmaceutical giants like Eli Lilly and Co. and Pfizer Inc. in the past. [read post]
19 Apr 2021, 9:37 am by Deb Givens
Circuit Court of Appeals on Tuesday revived a proposed class action against Janssen’s Actelion Pharmaceuticals Ltd accusing the company of extending its patent monopoly on its pulmonary artery hypertension drug Tracleer past the patent’s expiration date. [read post]